Jon Lamb
Follow
Get notifications in MyBN when activity occurs.
Jon Lamb
Non-Executive Director / AFT Pharmaceuticals
Jon Lamb has led the planning, marketing and restructuring of companies throughout his career.
He was chief executive of Beecham in New Zealand and marketing manager in Australia and South Africa; chief executive of Nylex in New Zealand; managing director within the rural division of Fletcher Challenge; director of Southland Frozen Meats, and marketing director of the New Zealand Kiwifruit Marketing Board.
Mr Lamb was also a director of Virionyx, a New Zealand company that developed an antiviral drug designed to combat AIDS. He was deputy chair of Australian diagnostic company ATF Group that developed a real time tool for measuring the Hepatitis B virus in individual patients.
He was chief executive of Beecham in New Zealand and marketing manager in Australia and South Africa; chief executive of Nylex in New Zealand; managing director within the rural division of Fletcher Challenge; director of Southland Frozen Meats, and marketing director of the New Zealand Kiwifruit Marketing Board.
Mr Lamb was also a director of Virionyx, a New Zealand company that developed an antiviral drug designed to combat AIDS. He was deputy chair of Australian diagnostic company ATF Group that developed a real time tool for measuring the Hepatitis B virus in individual patients.
Lists and Charts
Total Shareholder Return as at 31/10/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 1013th | AFT Pharmaceuticals | -10% | 1% |
1740 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Roles
Year started and most recent title
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | AFT Pharmaceuticals | $181.0m |
1334 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Person Activity
| NEW ROLE: Non-Executive Director, AFT Pharmaceuticals | 03 Nov 2020 |
